JNJ

Abbott May Be Doing The Right Thing At The Wrong Time
Seeking Alpha
Fri, 10/21/11 - 09:57 am
Abbott Laboratories
reorganization
Amgen
Biogen Idec
Bristol-Myers Squibb
GSK
JNJ
Boston Scientific
Medtronic
Pfizer
Roche
Pharmasset
Abbott Breakup Follows Familiar Pattern
Seeking Alpha
Thu, 10/20/11 - 08:56 am
Abbott Laboratories
reorganization
JNJ
Eli Lilly
SAC Faces SEC Probe Into Johnson & Johnson Cougar Move, WSJ Says
Bloomberg
Thu, 10/20/11 - 08:54 am
SAC
SEC
JNJ
M&A
Cougar Biotechnology
J&J’s Doxil/Caelyx shortages affect ovarian cancer trials
FT.com
Wed, 10/19/11 - 12:04 pm
JNJ
drug shortages
Doxil
Caelyx
ovarian cancer
5 Top Birth Control Stocks To Hold As Contraception Skyrockets Due to Recession
Seeking Alpha
Tue, 10/18/11 - 09:01 am
contraceptives
birth control
JNJ
Merck
Pfizer
Teva Pharmaceuticals
J&J Third-Quarter Profit Declines on Generics
Bloomberg
Tue, 10/18/11 - 09:00 am
earnings
generics
JNJ
Anadys acquisition sign of more to come
The Deal
Tue, 10/18/11 - 08:53 am
Anadys
Roche
Merck
JNJ
Achillion
M&A
Indenix
Bristol-Myers Squibb
Earnings Preview: Johnson & Johnson
Yahoo/Zacks
Sat, 10/15/11 - 12:57 pm
JNJ
J&J Unit Cleared of Liability for Alleged Levaquin Injuries
Bloomberg
Fri, 10/14/11 - 11:37 am
JNJ
antibiotics
Levaquin
Ortho-McNeil-Janssen
Johnson & Johnson Third Quarter Earnings Sneak Peek
Yahoo/Wall St. Cheat Sheet
Thu, 10/13/11 - 10:57 am
earnings
JNJ
Amgen
Abbott Laboratories
Boston Scientific
J&J Didn’t Warn Levaquin Riskier Than Rivals, Lawyer Argues
Bloomberg
Thu, 10/13/11 - 10:53 am
JNJ
antibiotics
Levaquin
Ortho-McNeil-Janssen
Johnson & Johnson: Dividend Stock Analysis
Seeking Alpha
Mon, 10/10/11 - 10:59 am
JNJ
dividends
Seeking Diversification Through Drug Company Dividend Stocks
Seeking Alpha
Thu, 10/6/11 - 12:00 pm
dividends
JNJ
Pfizer
Novartis
GSK
Merck
Sanofi
Abbott Laboratories
AstraZeneca
Amgen
Eli Lilly
Bristol-Myers Squibb
Millennium withdraws cancer drug application
Bizjournals.com
Thu, 10/6/11 - 11:56 am
Millennium
Velcade
follicular lymphoma
JNJ
Brand Power To The People: J&J Takes Lead In Forbes Ranking
Forbes
Thu, 10/6/11 - 09:22 am
JNJ
branding
Rivaroxaban Roundup: NEJM Perspective on FDA Panel, ATLAS-ACS Will Be an AHA Late-Breaker
Forbes
Thu, 10/6/11 - 09:18 am
FDA
rivaroxaban
Xarelto
Bayer
JNJ
J&J To Pay $48M To Man Hurt By Motrin
Pharmalot
Wed, 10/5/11 - 10:57 am
Motrin
JNJ
settlements
J&J Directors Win Dismissal of Investor ‘Red Flags’ Suit
Bloomberg
Wed, 10/5/11 - 09:56 am
JNJ
investors
recalls
Omnicare
Valeant Pharma Offer Tops Paladin's
Yahoo/Zacks.com
Fri, 09/30/11 - 09:29 am
Valeant Pharmaceuticals
Paladin
Cephalon
JNJ
Dermik
Sanofi
Rivaroxaban Meets Primary Endpoint in ATLAS ACS TIMI 51
Forbes
Fri, 09/30/11 - 09:26 am
rivaroxaban
JNJ
Xarelto
acute coronary syndrome
Bayer

Pages